Page 8 - Kumar Paul News Today

4 Min Read NEW DELHI (Reuters) -India’s most populous state will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia’s Sputnik V, a state official said on Thursday. A man speaks on the phone as a doctor tries to revive his wife inside an emergency ward of a government-run hospital, amidst the coronavirus disease (COVID-19) pandemic, in Bijnor district, Uttar Pradesh, India, May 11, 2021. RE...

Exclusive-Indias most populous state to spend up to $1.36 billion on COVID shots amid shortage By Krishna N. Das Reuters NEW DELHI (Reuters) -Indias most populous state will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russias Sputnik V, a state official said on Thursday. The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe s...

Integrated participatory efforts to combat drug abuse stressed 385 RAJSHAHI, May 10, 2021 (BSS)- Integrated participatory efforts of all government and non-government entities concerned have become crucial to combat the abuses of drugs along with its illicit trading and trafficking. There is no alternative to make all the existing movements and efforts of preventing drug abuse effective and fruitful to protect the young generation from further degradation. Administrative officials and developme...

Reuters Reuters 28 April, 2021, 2:11 pm FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS (Reuters) – U.S. drugmaker Merck & Co joined Gilead Sciences on Tuesday in lending support to India as the world’s second-most populous country scrambles to address drug shortages and bring a raging new wave of C...

  Gilead Sciences Inc said on Monday it will give India at least 450,000 vials of its antiviral drug remdesivir and help boost production, as the worlds second-most populous country reels from surging coronavirus cases. Remdesivir is approved in India for restricted emergency use to treat severe COVID-19 cases, but hospitals are facing supply shortages due to indiscriminate use and the drug is being sold at over 10 times its listed price in the black market. The shortage has raised concerns...

Gilead to ship 450,000 remdesivir vials to India as virus cases surge Gilead Sciences Inc said on Monday it will give India at least 450,000 vials of its antiviral drug remdesivir and help boost production, as the world’s second-most populous country reels from surging coronavirus cases. Remdesivir is approved in India for restricted emergency use to treat severe COVID-19 cases, but hospitals are facing supply shortages due to indiscriminate use and the drug is being sold at over 10 times its...

US drugmakers step up supplies as India battles COVID-19 surge Toggle share menu Advertisement US drugmakers step up supplies as India battles COVID-19 surge FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany on Apr 18, 2020. (Ulrich Perrey/Pool via Reuters) 27 Apr 2021 11:30PM (Updated: 27 Apr 2021 11:33PM) Share this content Bookmark CALI...

WHO IS DILIP KUMAR PAUL? Dilip Kumar Paul   The 64-year-old leader hailed from a traditional business family in Silchar and completed his B.Com from Gauhati University in 1977. In 1983, Paul joined the BJP as a primary member in the Cachar district. From 1997 to 2002, he was the BJP Ward President of Silchar. Later in 2012, the Assamese leader became the President of the BJP Town Mandal Committee.   Paul was elected as the Member of Legislative Assembly f...

ABC News Turn on desktop notifications for breaking stories about interest? OffOn The WHO said the global infection rate was approaching the highest so far. • 7 min read COVID-19 emergency plagues Brazil, hospitals overflow with patients Field hospitals in Brazil are overflowing and thousands of hospitals are short or out of sedatives. Critics blame the surge on Brazil’s President Jair Bolsonaro for shunning masks and social distancinManish Swarup/AP LONDON -- The pandemic is reaching dea...

April 13, 20211:05 PM UTC IndiaIndia wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - govt official Reuters 1 minute read Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse/File Photo India wants Pfizer, Moderna and Johnson & Johnson to seek licence for their COVID-19 vaccines as soon as possible, a senior government official said on Tuesday, shortly after the gover...